[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"squamous-cell-carcinoma-of-esophagus\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:squamous-cell-carcinoma-of-esophagus":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100497598","an-exploratory-study-of-ctdna-mrd-in-predicting-the-efficacy-of-esophageal-squamous-cell-carcinoma-100497598",false,"NCT05759325","An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma","Application of ctDNA-MRD in the Prediction of Curative Effect, Recurrence Monitoring and Prognosis Evaluation of Esophageal Squamous Cell Carcinoma (ESCC) During Perioperative Treatment","Inclusion Criteria:\n\n1. Patients with stage II-IVA Esophageal squamous cell carcinoma confirmed by clinical pathological staging;\n2. ≥18 years;\n3. Eastern Cooperative Oncology Group performance status score (ECOG PS) is 0 \\~ 1 points;\n4. Expected survival time ≥ 6 months;\n5. Patients agree and have the ability to follow the planned study visits, laboratory tests and other research steps.\n\nExclusion Criteria:\n\n1. Patients with other malignant tumors;\n2. Patient had undergone surgery before admission;\n3. Pregnant or lactating women;\n4. Patients with other serious diseases;\n5. Patients who could not understand the experiment content and could not cooperate with them and refused to sign the informed consent form;\n6. Patients with contraindications to radiotherapy and chemotherapy;\n7. Other researchers think it is not suitable.","ALL","18 Years","80 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to observe and evaluate the correlation between ctDNA-MRD and the therapeutic effect and prognosis of stage II-IVA operable esophageal squamous cell carcinoma.",[25],"Squamous Cell Carcinoma of Esophagus",[27,28],"ESCC","ctDNA","NOT_YET_RECRUITING","2023-02-25",{"date":32,"type":33},"2023-03-08","ACTUAL",{"date":35,"type":21},"2023-03",{"date":37,"type":21},"2026-12",{"name":39,"class":40},"Guangzhou Institute of Respiratory Disease","OTHER"]